# Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
> **CPSC recall** · 2025-12-18 · 26157 · 1 injuries reported
## Recall
- **Number:** 26157
- **Date:** 2025-12-18
- **Injuries reported:** 1
## Products

Mamisan Pain Relieving Topical Ointment

## Hazards

The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.

## Remedies

Repair

## Manufacturer(s)

MiramarLab, of Doral, Florida

## Retailer(s)

Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.

## Country of manufacture

United States

## Description

This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.

## Source
- [CPSC recall page](https://www.cpsc.gov/Recalls/2026/Plantimex-Recalls-Mamisan-Lidocaine-Ointment-Containers-Due-to-Risk-of-Serious-Injury-or-Death-from-Child-Poisoning-Violates-Mandatory-Standard-for-Child-Resistant-Packaging)
---
*AI Analytics · CC0 1.0*